Transurethral injection of polyacrylamide hydrogel (Bulkamid(R)) for the treatment of recurrent stress urinary incontinence after failed tape surgery
Abstract
The objective of this study was to evaluate the cure effect of a transurethral injection of Bulkamid(R) for recurrent female stress and mixed urinary incontinence in women who had undergone failed tape surgery. Our hypothesis was that cure effect of Bulkamid(R) is positive in patients when previous tape anti-incontinence surgery has been unsuccessful.
Design: Retrospective clinical study. Settings: Department of Obstetrics and Gynecology, 1st Medical Faculty, Charles University and General Faculty Hospital in Prague.
Results: The mean age of patients was 71.03 years, mean body mass index (BMI) 29.12 and mean parity 1.91. The cough test showed that 4/34 (11.8%) of patients had negative results for this test after the operation.
The ICIQ-UI SF questionnaire showed that 14/34 (41.2%) of our patients were dry or improved after surgery. The mean VAS score was 62.4 after the operation.
The Likert score was 4 or 5 (cured or improved) after the operation for 88.2% of patients. Conclusions: Our hypothesis that the cure effect of Bulkamid(R) operation would be positive in patients who have undergone previous unsuccessful tape anti-incontinence surgery was partially confirmed.
The Likert and VAS scores indicate that the effect of Bulkamid(R) surgery is good; however, an evaluation of the cure effect of this procedure based on the ICIQ-UI SF score is less positive. This kind of operation, which is minimally invasive, is less arduous for patients, and it is also suitable for patients who have refused further surgical treatment.